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Immunity to intestinal helminths is known to require both innate and adaptive components
of the immune system activated along the Type 2 IL-4R/STAT6-dependent pathway.
We have found that macrophage migration inhibitory factor (MIF) is essential for the
development of effective immunity to the intestinal helminth Heligmosomoides polygyrus,
even following vaccination which induces sterile immunity in wild-type mice. A chemical
inhibitor of MIF, 4-IPP, was similarly found to compromise anti-parasite immunity. Cellular
analyses found that the adaptive arm of the immune response, including IgG1 antibody
responses and Th2-derived cytokines, was intact and that Foxp3+ T regulatory cell
responses were unaltered in the absence of MIF. However, MIF was found to be an
essential cytokine for innate cells, with ablated eosinophilia and ILC2 responses, and
delayed recruitment and activation of macrophages to the M2 phenotype (expressing
Arginase 1, Chil3, and RELM-α) upon infection of MIF-deficient mice; a macrophage
deficit was also seen in wild-type BALB/c mice exposed to 4-IPP. Gene expression
analysis of intestinal and lymph node tissues from MIF-deficient and -sufficient infected
mice indicated significantly reduced levels of Arl2bp, encoding a factor involved in
nuclear localization of STAT3. We further found that STAT3-deficient macrophages
expressed less Arginase-1, and that mice lacking STAT3 in the myeloid compartment
(LysMCrexSTAT3fl/fl) were unable to reject a secondary infection with H. polygyrus. We
thus conclude that in the context of a Type 2 infection, MIF plays a critical role in polarizing
macrophages into the protective alternatively-activated phenotype, and that STAT3
signaling may make a previously unrecognized contribution to immunity to helminths.
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INTRODUCTION
Intestinal helminths constitute the most prevalent group of parasites in the human population
today, with around 1.5 billion people infected throughout the tropical and sub-tropical zones
of the globe (1, 2). While drugs are available that temporarily clear intestinal parasites, therapy
does not confer immunity to re-infection. Strategies aiming to boost the immune system through
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vaccination are constrained by a lack of understanding of basic
mechanisms of resistance to infection, including the relative
roles of innate and adaptive immunity in expelling parasites
(3). Thus, while CD4+ T cells are essential drivers of anti-
helminth immunity, parasite expulsion requires activation of
innate effector cell populations (4, 5). In the case of the
mouse model parasite Heligmosomoides polygyrus, the most
critical effector is likely to be the alternatively activated (M2)
macrophage induced through T-cell derived IL-4/-13 (6, 7).
Signaling through the IL-4Rα subunit is essential for M2
activation, and is known to require STAT6 activation and nuclear
translocation (8, 9). However, the role of other STAT factors in
immunity to helminths has been little explored (10).
We now identify a key player in immunity to H. polygyrus
to be macrophage migration inhibitory factor (MIF), as
mice genetically deficient in this protein, or exposed to
pharmacological inhibitors of MIF, are unable to expel intestinal
worms normally. Although MIF has been classically associated
with type 1 inflammation during microbial exposure and sepsis
(11, 12), more recent studies have also identified a role for this
molecule in development of Th2 responsiveness to allergens
(13, 14). It has also been reported that antibody-mediated
neutralization of MIF in vivo increases the burden of Schistosoma
japonicumworms in the tissues of infectedmice (15). In addition,
we and others have found that M2 activation of macrophages
by IL-4 is amplified in the presence of MIF (16, 17). We
therefore decided to test the role of MIF in chronic infection with
H. polygyrus.
As described below, MIF-deficient animals show delayed
infiltration and activation across a broad range of innate
immune cell populations, including macrophages, type 2 innate
lymphoid cells (ILC2s) and eosinophils. Gene array analyses
of infected tissues pointed to a relatively circumscribed shift
in expression profile which included sharply reduced levels of
Arl2bp, a promoter of STAT3 function. Mice lacking STAT3 in
their myeloid compartment were found to phenocopy the MIF-
deficient mice in failing to reject a challenge infection of H.
polygyrus.Hence,MIF is an essential mediator in the activation of
the innate compartment for immunological clearance of parasitic
helminths from the gastrointestinal tract, in a manner dependent
at least in part upon signaling through STAT3.
MATERIALS AND METHODS
Mice and Parasites
BALB/c and MIF-deficient mice on the BALB/c background
(18) were bred in-house and housed in individually-ventilated
cages (IVCs) according to UK Home Office guidelines. Mice on
the C57BL/6 background expressing Cre recombinase under the
LysM promoter (19), and carrying flanking loxP (flox) sites either
side of the Stat3 locus, were bred as described previously (20).
Infections employed 200 L3 larvae of H. polygyrus in
200 µl water by oral gavage. Parasite lifecycles and collection
of excretory-secretory (HES) products were conducted as
previously described in CBAxC57BL/6 F1 mice (21). Granuloma
and adult worm counts were conducted after small intestines
were removed and sliced longitudinally. Three to four fecal
pellets were weighed and dissolved in 2ml dH20; 2ml of
saturated salt solution (400 g NaCl in 1 L dH20) was then added
and eggs enumerated using a McMaster egg counting chamber.
Egg counts are represented as eggs/g fecal material. For secondary
infections, mice were cleared of worms after infection with
H. polygyrus with pyrantel embonate Strongid-P paste (Elanco
Animal Health), given in 2 doses of 2.5mg dissolved in 200 µl
dH20 given on days 28 and 29 by oral gavage. After 2 weeks, mice
were re-infected with 200 L3 larvae.
In vivo Administrations
One mg of MIF inhibitor, 4-IPP (Tocris Bioscience #3249)
(22) dissolved in DMSO, or DMSO alone, was administered
intraperitoneally (i.p.) in 50 µl every other day, during H.
polygyrus infection [adapted from (17)]. Fifty ng of recombinant
MIF (R&D) in 50 µl PBS, or PBS alone, was administered i.p.
every other day, during H. polygyrus infection. rIL-33 (R&D)
was administered intranasally (200 ng in 50 µl PBS) to sedated
mice on days 0, 1 and 2, and lung tissue taken at day 3 for
analysis. Alternaria alternata antigen (Greer) was administered
intranasally (10 µg in 50 µl PBS) to sedated mice. BALF was
harvested 1 h later (adapted from (23). For vaccination, mice
were immunized with 5µg of HES i.p. in alum adjuvant, and
boosted on days 28 and 35 with 1 µg in alum before challenge
with H. polygyrus at day 42 (24).
Cell Isolation and Culture
Mesenteric lymph node (MLN) cell suspensions were prepared
directly by passage through 70µm nylon filters (BD) and placed
in RPMI1640 (Gibco) containing 10% FCS, 1% PenStrep (Gibco)
and 1% L-glutamine (Gibco) (complete RPMI). Cells were
restimulated for 72 h at 37◦C with either media alone or HES at
a final concentration of 1µg/ml with 1 × 106 cells, in triplicate.
Peritoneal exudate cells were collected by washing the peritoneal
cavity with 2 × 5ml RPMI1640 using a 23 gauge needle.
Red blood cells were removed by adding 3ml red blood cell
(RBC) lysis buffer (Sigma) for 4min, and washing with complete
RPMI. Peritoneal lavage used for ELISA analysis consisted of the
supernatant from the first 5ml wash following centrifugation to
pellet cells. Bronchoalveloar lavage was collected by washing the
lungs with 1ml ice-cold PBS. Lung tissue was digested in HBSS
(Gibco) supplemented with 4 U/ml Liberase TL (Roche) and 160
U/ml DNAse 1 (Sigma). Tissue was incubated at 37◦C for 25min,
passed through 70µm nylon filters (BD) and RBC-lysed before
cells were used for flow cytometric analysis.
Flow Cytometry
Cells were stained in 96-well round-bottomed plates. Prior to
antibody staining, cells were washed in PBS and stained with
LIVE/DEAD Fixable Blue (Invitrogen) at a 1/1000 dilution in
100 µl PBS for 20min at 4◦C. Then, Fc receptors were blocked
in 50 µl of FACS buffer containing 100µg/ml of naïve rat IgG
(Sigma) for 20min at 4◦C. Samples were then surface stained
for 20min in 20 µl of FACS buffer containing a combination of
the antibodies detailed below. Lineage markers for ILC2 negative
gating: CD3 (Biolegend 17A2), CD4 (Biolegend RM4-5), CD8α
(Biolegend 53-6.7), CD19 (Biolegend 6D5) CD49b (eBioscience
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DX5), Gr1 (Biolegend RB6-8C5), CD11c (Biolegend N418);
F4/80 (Biolegend BM8), CD11b (Biolegend M1/70), SiglecF (BD
E50-2440); ICOS staining for ILC2 used BioLegend C398.4A. To
measure intracellular IL-5, cells were first stimulated for 4 h at
37◦C in the presence of PMA (50 ng/ml), Ionomycin (1µg/ml),
and Brefeldin A (10µg/ml) (all from Sigma). For pSTAT6
staining, clone pY641 conjugated to AF647 (BD Cat No 558242)
was used. Following surface staining, cells were permeabilised
for 30min at 4◦C in Cytofix/Cytoperm solution (BD), and
then washed twice in 200 µl of Perm/Wash (BD). ILC2s were
stained for intracellular cytokine expression in Perm/Wash (BD)
using anti-IL-5 (eBioscience TRFK5). For Foxp3 (eBioscience,
FJK-16s), Arginase-1 (R&D Systems IC5868P), RELM-α [R&D
Systems 226033, labeled with AF647 (Invitrogen)] and Chil3
[R&D biotinylated goat anti-mouse combined with Streptavidin
PeCy7 (Biolegend)], samples were stained for surface markers
after which cells were permeabilised for 12 h at 4◦C in Fix/Perm
solution (eBioscience Foxp3 staining set), and then washed twice
in 200 µl of Perm/Wash (eBioscience Foxp3 staining set). After
staining, cells were washed twice in 200 µl of FACS buffer
before acquisition on the LSR II or Canto flow cytometers (BD
Bioscience) and subsequently analyzed using FlowJo (Tree Star).
Cytokine ELISAs
Cytokine levels were detected in culture supernatants and BALF
by ELISA using monoclonal capture and biotinylated detection
antibody pairs as follows, used at concentrations optimized
previously: IL-4 [11B11 + BVD6-24G2 (BD Pharmingen)]; IL-
13 [eBio13A + eBio1316H (eBioscience)]; IL-33 (R&D Duoset).
p-nitrophenyl phosphate (pNPP, 1 mg/ml, Sigma) was used as a
substrate. OD was measured at 405 nm on a Precision microplate
reader (Molecular Devices) and data analyzed using Softmax
Pro software.
Antibody ELISAs
Serum antibodies to HES were measured by ELISA as previously
described (7). Briefly, plates were coated with 1µg/ml HES in
carbonate buffer, blocked with 10% BSA in carbonate buffer, and
incubated with serial dilutions of sera. Antibody binding was
detected using HRP-conjugated goat anti-mouse IgA or IgG1
(Southern Biotech 1070–50 and 1040–50) and ABTS Peroxidase
Substrate (KPL), and read at 405 nm.
Gut Homogenate
Approximately 1 cm small intestine was homogenized in 500
µl 1x lysis buffer (Cell Signaling Technology Inc) plus 5 µl
phenylmethanesulfonyl fluoride solution (PMSF) (Sigma) using
a TissueLyser (Qiagen). Samples were centrifuged at 12,000 rpm
for 10min to remove debris and supernatants added to ELISAs,
at a 1:10 dilution, to measure RELM-α (Peprotech) and Chil3
(R&D). Levels were normalized to total protein contentmeasured
using a Bradford assay. The same ELISA sets were used to analyse
peritoneal lavage levels of RELM-α and Chil3.
Immunohistochemistry
Transverse sections were made from 2 cm of paraffin-embedded
small intestine, at a thickness of 4µm using a cryostat. For
MIF staining, sections were deparaffinized by immersing slides
in Histoclear (Brunel Microscopes Ltd) for 5min, and then
hydrated through 100, 95, and 70% ethanol successively. Antigen
retrieval was undertaken with citrate buffer (20mM citric acid+
0.05% Tween 20 at pH6) warmed to 95◦C for 20min. Sections
were blocked in 1x PBS with 1% BSA, 2% normal rabbit serum,
0.1% Triton X-100 and 0.05% Tween 20 for 30min at room
temperature and then incubated with rabbit α-MIF (Invitrogen)
at 1:2000 dilution in block buffer, and left overnight at 4◦C. Slides
were immersed in 3% H2O2 for 10min at room temperature,
and washed in PBS. Goat α-rabbit conjugated to biotin (Vector
Laboratories) at 5µg/ml in PBS was added for 1 h at room
temperature, in the dark. Following 2 washes in PBS, several
drops of ABC Vectastain (Vector Laboratories) were added
and slides left for 30min at room temperature, in the dark.
Slides were washed twice in PBS and DAB peroxidase solution
(Vector Laboratories) was added for 5min (until a brown stain
had developed). With water washes in between, the following
were added successively to counterstain the sections: Harris
hemotoxylin solution (Sigma), acid alcohol (75% ethanol +
1% HCl) and Scott’s Tap Water Substitute (ddH2O + 42mM
NaHCO3 and 167mMMgSO4). Slides were dehydrated through
75, 95, and 100% ethanol and then Histoclear added for 5min.
Coverslips were added with DPX mountant (Sigma) and slides
were left to dry overnight, in the dark. Pictures were taken using
a Leica DFC290 compound microscope and Leica Application
Suite software.
For fluorescent staining of macrophages, proximal small
intestinal tissue was harvested and longitudinally opened. Any
food matter was then gently removed by scraping and the tissue
rolled onto a toothpick. Tissue was immediately immersed in
OCT compound (Tissue-Tek), frozen on dry ice and stored at
−80◦C. Then, 13µm thick sections were cut using a cryotome
(Thermo Fisher), attached to positively charged microscope
slides (VWR), dried for 15min at room temperature and then
stored at −80◦C. For the staining procedure, tissue sections
were thawed at room temperature and dried for 15min under
airflow, followed by fixation with 4% paraformaldehyde in
PBS for 15min at room temperature. The sections were then
rinsed twice in PBS, permeabilised in PBS/0.1% saponin (Sigma-
Aldrich) and consecutively blocked using a solution of 10%
donkey serum (Abcam) and 0.3M glycine (Fisher Scientific) in
PBS for 60min at room temperature. After 2 washes in PBS/0.1%
saponin, primary staining was performed overnight at 4◦C in
PBS/1%BSA/0.1% saponin containing an antibody cocktail of: rat
anti-mouse CD68-FITC (FA-11, Biolegend used at 5 ug/mL), rat
anti-mouse EpCam-PE (G8.8, Biolegend, 2.5 ug/mL) and sheep
anti-human/mouse arginase 1 (R&D, 5 ug/mL). Stained tissue
sections were then washed 3 times in PBS/0.1% saponin and
secondary antibody staining was performed with donkey anti-
sheep AF647 (Abcam, 1/500) for 40min at room temperature.
This was followed by 3 washes in PBS/0.1% saponin and 2 PBS
washes. DAPI containing Vectashield mounting media (Vector)
and coverslips were applied prior to imaging using an EVOS FL
Auto 2 fluorescence microscope (Invitrogen). Mean fluorescence
intensity (MFI) of Arginase-1 staining in granulomas was
analyzed using the image analysis software Fiji (SciJava).
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RNA Extraction and Quantitative PCR
To isolate mRNA from MLN and duodenal tissue, samples were
first immersed in 1ml of Trizol (Invitrogen) and disrupted
using a TissueLyser (Qiagen) for 2min at 25Hz and then
stored at −80◦C until mRNA isolation was performed with the
Qiagen mRNA easy kit (Qiagen) according to manufacturer’s
instructions. For duodenal analysis, ∼0.5 cm of the uppermost
part of the duodenum was sampled. Briefly, tissue was first
disrupted using a TissueLyser (Qiagen), then 200 µl chloroform
was added and samples were centrifuged at 12,000 g for 15min at
4◦C. The upper aqueous layer was recovered and added to 500
µl of isopropanol, mixed, and stood at room temperature for
10min. The sample was then centrifuged again at 12,000 g for
10min at 4◦C. Pelleted RNA was washed once in 70% ethanol,
and allowed to air dry before being dissolved in 50 µl of DEPC-
treated water; 15 µl RNA was treated with DNAse (DNAFree
kit, Ambion), concentrations were determined using a Nanodrop
1000 (Thermo Scientific), and samples reverse-transcribed using
1–2 µg of RNA with M-MLV reverse transcriptase (Promega). A
PCR block (Peltier Thermal Cycler,MJ Research) was used for the
transcription reaction at 37◦C for 60min. Gene transcript levels
were measured by real-time PCR on a Roche Lightcycler 480 II,
in 10 µl total volume made up of 4 µl cDNA, 5 µl SYBR Green
(Roche), 0.3 µl of each primer (10µM), and 0.4 µl DEPC treated
water (Ambion) using standard conditions for 60 cycles. Target
gene expression levels were normalized against the housekeeping
gene GAPDH.
Primer sequences were as follows:
ARL2BP ADP-ribosylation factor-like binding protein
F: CGTATCCCAGGCTTCAACA
R: TGTGAGCAGCATGTCAAAGA
PHC2 Polyhomeotic 2
F: CCC ACA AAA TGG AAT GTA GAG G
R: ACT CCT CCG CGA TCT CCT.
Array and Analysis
Two independent array experiments were conducted; in one,
wild type BALB/c or MIF-deficient mice were infected with H.
polygyrus for 5 days with tissues from the duodenum and MLN
being collected and stored in RNA Later (Ambion) prior to
processing. Duodenal tissues from uninfected BALB/c and MIF-
deficient mice were also taken and stored (4 mice per group for
each condition). MLNs from uninfected mice were too small to
include in this experiment. In the second experiment, duodenal
tissues were taken from naive mice (day 0) as well as days 3 and
7 of H. polygyrus infection for both BALB/c and MIF-deficient
mice (4 mice per group for each condition).
Total RNA from tissues was extracted by firstly placing
tissue in RLT buffer (Invitrogen) and then homogenized using
a Tissue Lyser II (Qiagen) set for 2min at 25Hz. RNA
isolation was performed with the RNeasy mini kit (Qiagen)
according to manufacturer’s instructions. RNA amplification
and biotinylation prior to array hybridization was performed
using the Illumina TotalPrep RNA Amplification kit (Ambion)
according to manufacturer’s instructions. All samples were
checked for RNA quality prior to hybridization by Agilent 2100
Bioanalyzer (Agilent).
Data were generated at the Wellcome Trust Clinical Research
Facility (WTCRF) located at Western General Hospital, Crewe
Road South, Edinburgh, EH4 2XU. A total of 48 Illumina
MouseWG6_V2_0_R3_11278593_A arrays were QC analyzed
using the arrayQualityMetrics Bioconductor package to identify
sub-standard and/or outlier arrays. Three arrays were identified
as outliers and were removed from subsequent analyses.
Software and Statistics
All statistical analyses were performed using Prism (Graphpad
Software Inc.). Error bars on graphs display mean and standard
error the mean (SEM). Student’s t-test was used to compare
groups. n.s., not significant, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001.
Results are combined from several similar experiments unless
otherwise stated in the figure legend.
RESULTS
Abated Anti-helminth Immunity in the
Absence of MIF
A widely used model system for helminth infection is that of
H. polygyrus in which parasitic larvae invade the intestinal tract
and mature to luminal-dwelling adult worms releasing eggs into
the environment (25, 26). BALB/c mice are initially susceptible
to infection but are able to gradually reduce their worm load
over several weeks through amacrophage-dependent mechanism
(7), and are almost fully clear of adult worms (Figure 1A) and
fecal eggs (Figure 1B) by day 28 post-infection. We tested MIF-
deficient BALB/c mice and found that they were unable to
reduce adult worm burdens or egg output following a primary
H. polygyrus infection.
We then tested resistance ofMIF−/−mice to parasite infection
in two models of acquired immunity. In the first, immunity to
infection can be accelerated by a prior episode of abbreviated
infection, terminated by anthelmintic therapy (27); in this case,
alternatively-activated (M2) macrophages have been shown to be
essential for protection (28). We found that MIF-deficient mice
are unable to expel adult worms, which are mostly cleared by day
21 in the wild-typemice (Figure 1C). Secondly, we used a vaccine
model in which sterilizing immunity is elicited by immunization
with H. polygyrus excretory-secretory (ES) products in alum
adjuvant (24). In this setting, BALB/c mice show complete
protection but MIF-deficient animals fail to clear the parasites
(Figure 1D).
We also reproduced the phenotype using a pharmacological
inhibitor of MIF, 4-iodo-6-phenylpyrimidine (4-IPP), which acts
as a “suicide substrate” by covalently binding the N-terminal
proline required for catalytic activity (17, 22). Mice receiving this
inhibitor showed significantly greater susceptibility than vehicle-
treatedmice toH. polygyrus, in terms of both adult worm burdens
and egg output (Figures 1E,F).
Although immunity generally correlates with the formation
of intestinal granulomas (29, 30), we found that MIF−/−
mice developed normal numbers of granulomas despite being
completely susceptible to infection (Figure 1G).
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FIGURE 1 | Compromised anti-helminth immunity in the absence of MIF. (A,B) Differential susceptibility of BALB/c and MIF−/− mice to primary infection with H.
polygyrus. Adult worm burdens in the small intestine (A) and fecal egg counts (B) were determined at days 14 and 28 post-infection with 200 H. polygyrus larvae by
gavage. Data shown are combined from 3 independent experiments. (C) Differential induction of immunity following drug-abbreviated primary infection in BALB/c and
MIF−/− mice. At day 28 following infection with H. polygyrus, mice were given 2.5mg of pyrantel embonate by oral gavage, twice over 24 h. After a further 14 days,
mice were reinfected (or infected for the first time in 1◦ groups). Adult worms were enumerated at day 21 post infection. Data shown are combined from 2
independent experiments. (D) Differential expression of vaccine-induced immunity in BALB/c and MIF−/− mice. At day 0, mice were injected with 10 µg of HES in
alum, or PBS-alum control, followed by booster injections of 1 µg HES or PBS at days 28 and 35. On day 42 all mice were infected with H. polygyrus. Adult worm
burdens were counted at day 21 post-infection. Data shown are combined from 2 independent experiments. (E,F) The MIF inhibitor 4-iodo-6-phenylpyrimidine (4-IPP)
inhibits immunity in BALB/c mice infected with H. polygyrus. 1mg 4-IPP in DMSO or DMSO alone was injected i.p. at days −1, 0, 2, 4, and 6 post-infection. Adult
worms (F) and egg burdens (G) were enumerated at day 28 post-infection. Data shown are combined from 2 independent experiments. (G) Numbers of intestinal
granulomas in BALB/c and MIF−/− mice 14 days following primary infection with H. polygyrus. Data shown are combined from 2 independent experiments. n.s., not
significant, *p < 0.05, ***p < 0.001, ****p < 0.0001.
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Intact Adaptive Type 2 Responses in
MIF-Deficient Mice
Immunity to H. polygyrus following either drug-mediated
clearance, or HES vaccination, has been shown to be antibody-
dependent, in particular requiring IgG1 (24, 31). We therefore
compared serological responses to infection in wild-type and
MIF−/− mice but found no difference in serum IgG1 titer
(Figure 2A). In addition, both genotypes responded with equally
high anti-HES antibody titers following vaccination (Figure 2B),
although only the MIF−/− animals failed to expel parasites.
These findings implicated a deficiency in the cellular arm of the
response in the absence of MIF.
We then compared parasite-specific T cell responses, as
immunity to H. polygyrus is strongly Th2 dependent (32), by
challenging small intestine draining mesenteric lymph node
(MLN) cells from H. polygyrus-infected BALB/c and MIF−/−
mice with HES antigens. We found comparably robust IL-4 and
IL-13 responses in both strains (Figures 2C,D); no induction of
antigen-specific IFNγ responses above background was seen in
either strain (data not shown), indicating the susceptibility of the
MIF-deficient mouse cannot be explained by a switch to the Th1
mode of immunity.
Regulatory T cells (Treg) expressing the Foxp3+ transcription
factor are known to expand duringH. polygyrus infection (33, 34)
and render mice susceptible (35, 36). MLN cell populations were
analyzed by flow cytometry at 14 and 28 days post-infection,
and similar increases in Foxp3+ Treg numbers were seen in
both wild-type and MIF−/− mice infected with H. polygyrus
(Figure 2E). Increases in Treg frequency (as percentage of total
CD4+ cells) and Foxp3 intensity were also similar between the
two strains (data not shown), indicating that increased Treg
activity is not contributing to greater susceptibility in the gene-
targeted mice.
Impaired Innate Type 2 Responses in
MIF-Deficient Mice
We then analyzed innate immune cell responses in BALB/c
and MIF−/− mice at day 7 post-H. polygyrus infection. In the
wild-type animals, infection provokes a sharp increase in cell
numbers within the MLNs (Figure 3A), which is diminished in
the MIF−/− mice. Infection also results in activation of ILC2s
to express IL-5 which is almost totally ablated in the MIF-
deficient animals (Figure 3B), within an overall reduction of
ILCS in theMLN (Figure 3C). Likewise, cellular expansion in the
peritoneal cavity provoked by infection is profoundly reduced in
MIF-deficient mice (Figure 3D), as is eosinophilia (Figure 3E).
The loss of eosinophils in the absence of MIF has previously
been observed in both helminth infection and airway asthma
models (13, 37, 38). We also tested the MIF-dependence of
eosinophilia by administering the 4-IPPMIF inhibitor at the time
of H. polygyrus infection. Wild-type mice receiving this inhibitor
showed significantly reduced peritoneal eosinophilia compared
to animals treated with the DMSO vehicle alone (Figure 3F).
To ascertain whether ILC2 differentiation was intrinsically
compromised in MIF-deficient mice, we first tested the effects of
exogenous IL-33 injection on the activation of ILCs in the lung;
IL-33 drove equivalent IL-5+ ILC2 responses irrespective of MIF
genotype (Figure 3G). We then tested the response of mice to
airway challenge with Alternaria allergen, a potent stimulator of
the ILC2 population through provoking rapid release of IL-33
from the airway epithelium (39). The introduction of exogenous
Alternaria antigen elicited equivalent levels of IL-33 into the
bronchoalveolar lavage after 1 h in BALB/c and MIF-deficient
animals (Figure 3H), arguing that both the release of ILC2-
stimulating alarmins and the development of ILC2 responses to
these cytokines are intact in the MIF-deficient setting.
The diminished eosinophil responses in MIF-deficient mice
cannot readily account for their increased susceptibility, as
eosinophil-deficient1dblGATA mice retain their ability to expel
H. polygyrus following vaccination (24). In addition, the poor
ILC2 response observed did not translate into any shortfall in the
Th2 response that develops to parasite antigens (Figures 2C,D),
although it is possible that abated ILC2 production of IL-5
explains the deficient eosinophil responses in MIF−/− mice.
Type 2 Myeloid Responses in MIF-Deficient
Mice
We next analyzed myeloid subpopulations, which play critical
roles in mediating immunity in many helminth settings (7,
28, 40). To establish whether the absence of MIF resulted
in significant differences within the myeloid compartment, we
compared the phenotype of CD11b+ F4/80+ macrophages in
MIF-sufficient and -deficient mice. We found that, following
H. polygyrus infection, few viable lamina propria cells could
be recovered from either BALB/c or MIF-deficient mice and
hence populations were assayed from the peritoneal cavity, in
which there is extensive expansion and alternative activation of
macrophages during the first week of infection (41). Notably, the
increase in macrophage numbers was muted in the peritoneal
cavity of MIF-deficient mice (27% above naïve levels) compared
to wild-type animals (90% increased) (Figure 4A).
Because MIF has previously been shown to promote the
alternative activation of macrophages, alongside IL-4Rα-binding
cytokines (16), we measured expression of key alternatively-
activated macrophage (AAM)-associated gene products
Arginase-1, Chil3 (Ym1) and RELMα by a combination of
flow cytometry of peritoneal cell populations, and ELISA for
soluble proteins in peritoneal lavage fluids. By each of these
measures MIF−/− mice showed significant impairment of
alternative activation. Thus, the proportions of peritoneal
macrophages staining for Arginase-1 (Figures 4B,C) and
RELMα (Figures 4D,E) were significantly reduced in MIF-
deficient animals, as were levels of detectable Chil3 and RELMα
protein in the lavage following H. polygyrus infection (see
below). We also compared the level of IL-4-stimulated STAT6
phosphorylation in bone marrow-derived macrophages from
MIF-sufficient and deficient mice, and found no significant
differences (Figure 4F), indicating that the requirement for MIF
acts downstream, or independently of, IL-4 receptor ligation.
We next examined the in vivo effects of pharmacological MIF
inhibition on the expression of AAM markers; administration of
4-IPP significantly reduced the number of CD11b+ Arginase-1+
Frontiers in Immunology | www.frontiersin.org 6 October 2019 | Volume 10 | Article 2375
Filbey et al. MIF in Type 2 Immunity
FIGURE 2 | Intact adaptive and regulatory responses in MIF-deficient mice. (A) Comparable anti-helminth humoral immunity in BALB/c and MIF−/− mice. Titers of
HES-specific IgG1 serum antibodies from naïve and day 28-infected BALB/c and MIF−/− mice, assessed by ELISA. Data are representative of two independent
experiments. (B) Comparable anti-helminth humoral immunity in HES-vaccinated BALB/c and MIF−/− mice. Parasite-specific antibody responses in vaccinated
BALB/c and MIF−/− mice. HES-specific serum IgG1 levels were measured by ELISA on the day of challenge infection. Data are representative of two independent
experiments. (C,D) Comparable adaptive type 2 immune responses in BALB/c and MIF−/− mice. Th2 cytokines from culture medium of MLNC from naïve and day 14
H. polygyrus-infected BALB/c and MIF−/− mice, restimulated with 1µg/ml HES or media for 72 hours. Levels of IL-4 (C) and IL-13 (D) were measured by ELISA. Data
are representative of two independent experiments. (E) Regulatory cell induction by helminth infection is comparable between BALB/c and MIF−/− mice. Numbers of
CD4+Foxp3+ Treg cells within MLNs from BALB/c and MIF−/− mice at days 14 and 28 post-infection with H. polygyrus. Data are representative of two independent
experiments. n.s., not significant, **p < 0.01, ***p < 0.001.
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FIGURE 3 | Impaired innate type 2 responses in MIF-deficient mice. (A) Total numbers of MLN cells recovered from BALB/c and MIF−/− mice 7 days following H.
polygyrus infection. Data are representative of two independent experiments. (B) Differential induction of ILC2s in BALB/c and MIF−/− mice following H. polygyrus
infection. Total numbers of IL-5+ ICOS+ lineage− ILC2s within MLNC from naïve and d7 H. polygyrus-infected BALB/c and MIF−/− mice. Data are representative of
two independent experiments. (C) Representative flow cytometry plots of ICOS vs. Lineage markers in MLN cells from BALB/c and MIF−/− naive mice and 7 days
following H. polygyrus infection. (D) Total numbers of peritoneal lavage cells recovered from BALB/c and MIF−/− mice 7 days following H. polygyrus infection. Data are
representative of two independent experiments. (E) Differential induction of eosinophilia in BALB/c and MIF−/− mice following H. polygyrus infection. Total numbers of
eosinophils (SiglecF+ CD11b+) in naïve and H. polygyrus-infected BALB/c or MIF−/− mice within the peritoneal lavage, at day 7 post-infection. Data are representative
of two independent experiments. (F) The MIF inhibitor 4-IPP inhibits eosinophilia in BALB/c mice infected with H. polygyrus. Eosinophil numbers at day 7
post-infection with H. polygyrus in BALB/c following administration of 1mg of the MIF inhibitor, 4-IPP, assessed as SiglecF+CD11b+ cells within the peritoneal lavage.
Results are combined from two experiments with similar results. (G) MIF−/− mice do not have an intrinsic defect in ILC2 induction. IL-5+ ILC2s as a proportion of live
cells in digested lung tissue of BALB/c or MIF−/− mice treated intranasally with PBS or rIL-33, measured by flow cytometry. Data are representative of two
independent experiments, and were analyzed by nonparametric statistics. (H) MIF−/− mice have normal ability to release the key alarmin IL-33 upon stimulation.
Levels of IL-33 in BALF of BALB/c or MIF−/− mice 1 h after intranasal administration of 10 µg Alternaria antigen, measured by ELISA. Results are combined from two
experiments with similar results. n.s., not significant, *p < 0.05, **p < 0.01.
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FIGURE 4 | Type 2 myeloid responses in MIF-deficient mice. (A) MIF−/− mice have a reduced capacity for induction of macrophages after helminth infection. Total
macrophage (CD11b+F4/80+) numbers within the peritoneal cavity of BALB/c and MIF−/− mice at day 6 post-infection with H. polygyrus, or in naïve mice. Data are
representative of two independent experiments. (B) Percentage of peritoneal macrophages that are Arginase+ in BALB/c and MIF−/− mice at day 3 post-infection
with H. polygyrus, or in naïve mice. Results are combined from two experiments with similar results. (C) Representative flow cytometry plots of CD11b and Arginase-1
staining in peritoneal macrophages from BALB/c and MIF−/− mice. (D) Percentage of peritoneal macrophages that are RELMα+ in BALB/c and MIF−/− mice at day 6
post-infection with H. polygyrus, or in naïve mice. Data are representative of two independent experiments. (E) Representative flow cytometry plots of CD11b and
RELM-α staining in peritoneal macrophages from BALB/c and MIF−/− mice. (F) STAT6 phosphorylation of bone marrow-derived macrophages in response to
20 ng/ml recombinant IL-4, measured by flow cytometry at the times indicated. (G) The MIF inhibitor, 4IPP, can replicate the macrophage deficit of MIF−/− mice in
BALB/c mice after H. polygyrus infection. Percentage of peritoneal macrophages that are Arginase-1+ in DMSO- or 4IPP- treated BALB/c mice at day 3 post-infection
with H. polygyrus, or in naïve mice receiving no treatment. Data are representative of two independent experiments. (H) Number of peritoneal macrophages that are
Chil3+ in DMSO- or 4IPP-treated BALB/c mice at day 7 post-infection with H. polygyrus. Results are combined from two experiments with similar results. (I) Levels of
RELMα and Chil3 measured by ELISA in peritoneal lavage fluid of DMSO- or 4IPP- treated BALB/c mice at day 7 post-infection with H. polygyrus. Data are
representative of two independent experiments. *p< 0.05, **p < 0.01, ***p < 0.001.
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(Figure 4G) and Chil3+ (Figure 4H) peritoneal macrophages
after H. polygyrus infection, as well as the levels of both Chil3
and RELMα protein in the peritoneal lavage fluid of BALB/c
mice (Figure 4I).
To test whether MIF is directly responsible for the
alternative activation of macrophages, we evaluated the effects
of administering recombinant MIF into the peritoneal cavity
of MIF-deficient mice. Such treatment restored the proportions
of Chil3+ AAM in this site after H. polygyrus infection to
levels comparable with wild-type mice (Figure 5A), but did not
rescue the significant deficit in ILC2 cells in the same location
(Figure 5B). Exogenous MIF was able to partially restore protein
levels of Chil3 and RELM-α in the peritoneal lavage fluid of
MIF−/− mice (Figures 5C,D), although remaining significantly
below those of the wild-type mice, and no eosinophilia was
elicited (data not shown). Furthermore, these products were also
upregulated in small intestinal tissues of H. polygyrus-infected
MIF-deficient mice (Figures 5E,F). As intraperitoneal delivery of
MIF did not restore resistance to the parasite infection (data not
shown), it is likely that localized production and release within
the intestinal tract may be required for effective recruitment and
activation of tissue macrophages at the site of infection.
While peritoneal macrophages may mirror the phenotype of
the intestinal population, it is important to also study those cells
closely associated with larval parasites in the submucosa of the
small intestine, where H. polygyrus is found for the first 8 days of
infection. We used immunofluorescence imaging to characterize
the patterns of macrophage activation and accumulation around
larval parasites, and their expression of Arginase-1 which is
known to be required for immunity to this helminth (28).
Surprisingly, local macrophage infiltration and overall Arginase-
1 expression did not significantly differ in infected MIF−/− mice
(Figure 6A), and although the intensity of Arginase-1 staining
in gene-deficient tissues was marginally weaker at day 4 of
infection (Figure 6B), by day 6 it was as ubiquitous as in the
wild-type controls (Figure 6C). In both examples, Arginase-1
is disseminated throughout the granuloma, indicating that it is
either or both expressed by cells other than macrophages, and/or
released extensively into the extracellular milieu from those cells
which express it. Immunohistochemical staining was also used to
identify widespread expression ofMIF in intestinal tissues in vivo;
in particular, MIF was intensely expressed within the granulomas
centered around immobile larvae (Figure 6D), at the foci of the
local immune response to intestinal helminth infection.
Gene Expression in H. polygyrus-Infected
MIF-Deficient Mice
To gain insight into possible signaling and effector molecules
dependent upon MIF in helminth infection, we compared gene
expression profiles of MIF-sufficient and –deficient mice by array
analyses of duodenal tissue taken 3, 5, and 7 days following H.
polygyrus infection, as well as MLN sampled on day 5. As shown
in Figures 7A,B, relatively few genes showed major expression
changes but among them were Arl2bp, a little-studied gene
encoding a protein which stabilizes nuclear localization of the
STAT3 transcription factor (42), and Phc2, a central component
of the Polycomb 1 complex that maintains epigenetic imprinting
(43). In addition, a number of other genes showed either smaller
or more transient reductions in levels in H. polygyrus-infected
MIF−/−mice compared to wild-type, including Retnlb (encoding
RELM-β) and Pla2g1b, two epithelial-expressed genes reported to
possess direct anti-helminth properties (44, 45).
STAT3 Signaling Contributes to Immunity to
H. polygyrus
Gene expression differences for Arl2bp and Phc2 were confirmed
by RT-PCR on MLN samples at day 5 of infection of wild-
type and MIF-deficient mice (Figures 7C,D). As abated Arl2bp
expression may compromise STAT3 signaling, we then tested
mice in which STAT3 expression had been blocked in myeloid
lineages through transgenic expression of Cre recombinase under
the LysM promoter, combined with homozygous alleles for a
flox-flanked STAT3 (46). We first examined CD11b+F4/80+
peritoneal macrophages from H. polygyrus-infected mice, and
found significantly fewer cells expressed intracellular Arginase-
1 in mice carrying the myeloid-restricted deletion (Figure 8A);
notably, Chil3+ cell numbers were similar, albeit low, in both
genotypes (Figure 8B). We also collected peritoneal lavage fluid,
and found significantly lower Arginase enzymatic activity in the
STAT3-conditionally deleted mice (Figure 8C). In addition, we
measured soluble Chil3 in the lavage fluid, which rather than
being inhibited in mice lacking myeloid cell STAT3 expression,
actually showed a significant increase (Figure 8D).
As the C57BL/6 background is fully susceptible to primary H.
polygyrus infection, we then evaluated immunity to a secondary
challenge with H. polygyrus following chemotherapeutic
clearance of the primary infection. In wild-type mice lacking the
Cre allele, there was significant protection against challenge, but
in myeloid-specific STAT3-deleted animals, parasite loads were
similar in primary and secondary infection, showing a failure of
protective immunity in the STAT3-deficient setting (Figure 8E).
DISCUSSION
The crucial role of innate immune cell populations in immunity
to helminths is well recognized (5, 47), but the molecular
mediators required for their activation have not all been
identified. Here we report that MIF is a critical cytokine
required for clearance of the intestinal parasite H. polygyrus,
impacting on multiple type 2 innate cell populations while not
significantly affecting adaptive B or T cell responses. Although
previously viewed as a pro-inflammatory agent in settings of
sepsis and microbial challenge (48), our work and that of others
demonstrate that its role is context-dependent, so that in the
presence of the pivotal type 2 cytokine IL-4, MIF will synergize
to induce characteristic M2 products including Chil3, RELMα
and Arginase-1 (16, 17). Significantly, the activity of MIF is not
confined to the macrophage lineage, with evident lesions in ILC
numbers, and a profound loss of eosinophils, in MIF-deficient
animals. These multiple facets of MIF are characteristic of a
protein with a range of diverse activities that are remarkable for a
protein of only 114 amino acids, and one discovered at the dawn
of the cytokine era (49, 50). For example, MIF is also a non-
consensus ligand of chemokine receptors (51), an inhibitor of
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FIGURE 5 | rMIF rescues the macrophage phenotype of MIF-deficient mice. (A) Administration of recombinant MIF can rescue the MIF−/− phenotype after H.
polygyrus infection. Percentage of peritoneal macrophages (CD11b+ F4/80+) that are Chil3+ in BALB/c or MIF−/− mice treated with PBS or 50 µg recombinant MIF
intraperitoneally, at day 7 post-infection with H. polygyrus, or in naïve mice. Results are combined from two experiments with similar results. (B) Percentage of PL cells
that are IL-5+ ILC2s from the same experiments as (A). Results are combined from two experiments with similar results. (C,D) Expression of Chil3 (C) and RELMα (D)
in peritoneal lavage fluid, measured by ELISA, from the same experiments as (A). Results are combined from two experiments with similar results. (E,F) Expression of
Chil3 (E) and RELMα (F) in small intestinal homogenate, measured by ELISA, from the same experiments as (A). Results are combined from two experiments with
similar results. n.s., not significant, *p < 0.05, **p < 0.01, ***p < 0.001.
intracellular signaling and inflammasome assembly (52, 53) and
a partner in a nuclear DNA-cleaving complex (54).
Immunity to H. polygyrus is known to require a potent type
2 response, dependent upon CD4+ Th2 cells driving a specific
IgG1 antibody response together with alternatively-activated
(M2) macrophages stimulated through the IL-4R (7, 28, 55).
Immunity can act in two distinct phases: firstly against tissue-
dwelling larvae which are immobilized and killed in the setting of
a challenge infection or an immunized host, and secondly against
luminal adults which are cleared by the combined action of
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FIGURE 6 | Myeloid cell infiltration around tissue larvae of H. polygyrus with expression of Arginase-1 and MIF. (A) M2 macrophages infiltrate the infection site of H.
polygyrus larvae in the small intestine. Arginase, CD68 and EpCam staining of granulomas around larval parasites in the small intestinal submucosa at days 4 and 6 of
H. polygyrus infection in BALB/c and MIF−/− mice. Images are representative of two experiments with similar results. (B,C) Analysis of intensity of Arginase staining in
granulomas at days 4 and 6 after H. polygyrus infection. For each group at each time point, granulomas were analyzed from 4 individual animals, and intensity data
pooled. Each data point represents an individual granuloma. (D) MIF is expressed in the infection site of H. polygyrus larvae in the small intestine. Intense staining of
polyclonal rabbit anti-MIF antibody is observed in the granulomas around larval parasites in the small intestinal submucosa at day 6 of H. polygyrus infection in
BALB/c mice, but not in MIF−/− animals or in sections stained with isotype control IgG. In addition, widespread specific antibody staining is seen throughout the
submucosal tissue. Images were collected on a Leica compound microscope. Scale bars represent 500 and 250µm.
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FIGURE 7 | Gene expression in H. polygyrus-infected MIF-deficient mice. (A) Volcano plot comparing gene expression in duodenal tissue from BALB/c and MIF−/−
mice 5 days after H. polygyrus infection. Genes of interest are labeled in red; other loci showing large and/or significant changes are labeled in blue. (B) Heat maps
from two gene expression experiments, on duodenal and MLN tissue for expression of selected genes 5 days after H. polygyrus infection in BALB/c and MIF−/− mice
(left hand panel), and of duodenal tissues at days 3 and 5 post-infection in the same genotype mice (right hand panel). Expression levels are colored from blue (lowest)
to yellow(highest) and in each case represent the mean of 4 replicates. (C,D) RT-PCR validation of Arl2bp (C) and Phc2 (D). MLNs were harvested for analysis at d 5
of H. polygyrus infection, and subject to RT-PCR using gene specific primers. ***p < 0.001, ****p < 0.0001.
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FIGURE 8 | Myeloid cell expression of STAT3 is required for optimal Arginase-1 expression and for secondary immunity to H polygyrus. (A) Peritoneal macrophages
were recovered from control and conditional STAT3 gene deleted mice, with genotypes of STAT3fl/flxLysM-Cre−/− and STAT3fl/flxLysM-Cre+/−, respectively, and
stained for surface CD11b and F4/80, together with intracellular Arginase-1. Staining was evaluated by flow cytometry. Data are pooled from three independent
experiments. (B) Expression of Chil3 within the same macrophage populations. Data are pooled from three independent experiments. (C) Peritoneal lavage fluids were
recovered from the same animals as in (A,B), and functional soluble arginase levels measured by an enzyme assay *p < 0.05. (D) Presence of Chil3 protein in the
same lavage fluids as (C) *p < 0.05. (E) Myeloid cell-specific deletion of STAT3 impairs secondary immunity. LysMCrexSTAT3fl/fl mice and STAT3fl/fl controls) were
infected with H. polygyrus and infections cleared with pyrantel embonate. Mice were subsequently challenged with a secondary infection, or infected for the first time
for primary controls, and adult worms counted in the small intestine at d21 post infection. Results are combined from two experiments with similar results. n.s., not
significant, *p < 0.05.
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activated myeloid and epithelial cells (26). Importantly, parasites
surviving immune attack in the tissues can emerge into the
lumen with diminished fitness, resulting in lower egg production
and shorter survival times. MIF deficiency was found not only
to compromise worm expulsion in both naive and vaccinated
animals, but also to result in significantly higher egg production
at day 14 (Figure 1B), confirming that early responses to the
tissue larvae are abated in the absence of MIF.
Among other innate cell populations, ILC2s can promote
the response, but are not sufficient for expulsion (56), while
eosinophils act to restrain the intestinal Th2 response to H.
polygyrus (57) and eosinophil-deficient mice clear parasites
promptly following immunization with a secreted antigen
vaccine (24). As MIF-deficient mice mounted a normal adaptive
B- and T cell response to infection, we concluded that these
mice must lack a key innate effector population, which we
propose are the IL-4R-dependent M2 macrophages. Indeed, even
in the presence of memory Th2 cells known to drive M2-
dependent immunity to H. polygyrus (28) immunity fails in the
absence of MIF, again suggesting lesion(s) in the macrophage
compartment. If so, this would argue that IL-4R ligation may
require supplementation through other signals to achieve the
fully activated M2 state required for worm expulsion. A further
interesting point is that MIF-deficient mice generated a similar
granuloma response to wild-type animals, and yet could not
trap parasites even following vaccination. As cell recruitment to
granulomas was similar in the two genotypes, and as MIF itself is
highly expressed in the WT granuloma, it may be that MIF acts
not at the level of differential cell recruitment, but by activating
cells locally to promote immunity.
It is known that numbers of macrophages in H. polygyrus
infection rapidly expand, notably in the peritoneal cavity,
and adopt the M2 phenotype characterized by production of
Arginase-1, Chil3 and RELMα (41). We noted a significant delay
in peritoneal macrophage activation in MIF-deficient animals,
with a lag also evident in production of these archetypal markers,
although the effect was less obvious at the tissue site of infection.
However, it is known that genetically resistant strains of mice
mount a more rapid response to H. polygyrus (7), suggesting that
retardation of M2 activation in the absence of MIF may account
for failure of immunity. We further established the role of
MIF in testing a pharmacological inhibitor, which recapitulated
both impaired expression of M2 gene products, and greater
susceptibility to infection, that are observed in the gene-targeted
mice. In addition, we established exogenous MIF could restore
the activation of peritoneal macrophages to the wild-type profile.
Previous work has demonstrated that immunity to
H. polygyrus is compromised by clodronate depletion of
macrophages (7), and by pharmacological blockade of Arginase-
1, a principal product of M2 macrophages (28). However,
we have yet to establish whether such macrophages activated
by MIF would be sufficient to confer immunity by adoptive
transfer to naive recipients. One obstacle to such an experiment
is that appropriate migration of the adoptively transferred
population to the site of infection may not occur, particularly
given that MIF is thought to arrest macrophage migration
in situ. We note, however, that in a related parasite model of
Nippostrongylus brasiliensis, in which larvae transit the lung
intranasal transfer of M2 macrophages significantly augments
anti-parasite immunity (58).
To further analyse the role of MIF in vivo, we next compared
gene expression profiles, in the intestinal tract and MLN. In
these tissues, disparities in M2 macrophage products were not
so apparent, but two transcripts markedly under-represented
in the MIF-deficient state were Arl2bp and Phc2. The former
is a STAT3 nuclear retention factor, raising the possibility that
STAT3 is required for functional macrophage activity in H.
polygyrus infection. While we did not observe any difference
in STAT3 phosphorylation following IL-6 or IL-10 stimulation
of wild-type or MIF-deficient cells (data not shown), Arl2bp
may manifest a more subtle effect on nuclear activity which
we could not detect. However, it has previously been shown
that Arginase-1 and Chil3 expression are STAT-3 dependent in
mammary epithelial cells (59), as is also the case for Arginase-1
in myeloid-derived suppressor cells (MDSCs) (60), which share
some characteristics with M2 macrophages. Although global
STAT3 deletion is lethal in mice, we were able to test animals with
a myeloid-specific conditional deletion of STAT3, which show
modest reduction in Arginase-1 expression during H. polygyrus
infection and lose the ability to expel parasites on secondary
exposure. As pharmacological inhibition of Arginase is also
able to block expulsion of this parasite (28), these data may
indicate that small changes in the timing or peak of Arginase
production are sufficient to alter the outcome of infection. In
addition, our finding that Chil3 is actually increased in myeloid-
specific STAT3-deficient mice which fail to expel, would argue
that despite its abundance, Chil3 is not a primary factor that
promotes helminth clearance.
As mentioned above, MDSCs commonly express Arginase.
They are also expanded in vitro by MIF (17, 61, 62), and their
development is in part STAT3-dependent (63). Furthermore,
MDSC transfer alone has been reported to hasten expulsion of
the nematode species N. brasiliensis from mice (64). In addition,
key enzymes such as amylases (Amy2a5, Figure 7B) which show
ablated gene expression in MIF-deficient mice are reported to be
up-regulated in tumor-associatedMDSCs (65). However,MDSCs
are a highly heterogenous grouping of myeloid cells (66), and
further definition of which, if any, subset of these cells may play a
role in helminth immunity will be an important future goal.
We summarize the interactions discussed in this paper in
Figure 9. While our data argue that in addition to IL-4R
signaling, MIF, and STAT3, are each involved in macrophage
immune function, we cannot exclude that other cell types
respond to these signals, and are integrally required for parasite
expulsion. For example, neutrophils play a role particularly
in primary infection, as depletion of Gr1+ cells compromises
primary immunity to H. polygyrus (24, 67) and can prime
macrophages for resistance to challenge infection with this
parasite (68).
Finally, in mice lacking MIF there was a substantial reduction
of a polycomb 1 complex gene, Phc2, which we are now exploring.
The polycomb complex mediates chromosomal imprinting (43)
which is a central feature of macrophage commitment and
innate immune memory (69–71). While Phc2 itself has yet to
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FIGURE 9 | Graphical summary of the role of MIF in immunity to H polygyrus.
Invading helminths elicit release of epithelial alarmins (IL-25 and IL-33) and
most likely, MIF. These innate activators act on macrophages and ILCs;
macrophages activated by MIF, and by IL-13 from ILCs, swarm around the
tissue helminth to form the granuloma. High levels of MIF are also produced
within the granuloma which may auto-stimulate macrophages, drive
Arginase-1 expression, and act on distant ILCs. ILC2s also produce IL-5
which stimulates eosinophilia in the tissues.
be implicated in macrophage differentiation, other polycomb
components are known to be involved (72), and epigenetic
modifications have been found to be essential to the phenotypes
of both M1 (73, 74) and M2 (75, 76) macrophages. Hence, there
may be a longer-term inability of macrophages to fully polarize
and form innate memory in the absence of MIF, which in turn
could explain the failure to expel parasites in vaccinated animals.
With this report, MIF may be seen as joining the
ranks of intestinal epithelial-derived mediators that recruit
and sustain innate immune responses. However, MIF is
produced and functions in many niches, and many critical
features underpinning the source, stimulus and regulation of
its expression remain to be determined. The discovery that
additional stimuli are required for optimal alternative activation
will also be important in defining the pathway through which the
M2 phenotype is controlled. Indeed, a number of co-activating
pathways for M2 macrophages have very recently been described
including surfactant protein A (77) andmarkers of apoptosis (78)
– as withMIF these ligands may prove indispensable in designing
future interventions to generate protective immunity to the range
of parasitic organisms for which type 2 immunity is critical.
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